You've Been Given the Gift of Life, Give it Back!

Welcome friends and family!

Thank you for visiting my blog. It documents my amazing journey from pre to post double lung transplant. I am a 37 year old mother and wife with Cystic Fibrosis who has been more greatly blessed than I could ever imagine possible!

It has been a bumpy ride, but God has given me strength, love, friendship, and, FINALLY, health. My prayers have been answered, my miracle was granted, and I want to share the joy of my new life with you.

If you are a first time visitor, please take a moment to watch The Miracle of Transplantation video below. To me, pictures speak a thousand words.

My entries begin in April of 2008 and my double lung transplant was December 10. Scroll down to my blog archive and you can read from the beginning or jump around. If you are looking for a specific topic, you can use the search engine.

Please feel free to contact me with questions or feedback, I would love to hear from you!

I hope I can help you to experience the love God has for each and every one of us!

May God Bless You with Miracles in Your Life! Nancy


..............................................................................................................

Tuesday, December 29, 2009

CFF News

FDA Advisory Panel Rules in Favor of AZLI

As we enter the holiday season, I am pleased to share with you some very positive news. Yesterday, a potential CF drug called aztreonam lysine for inhalation was recommended for approval by an advisory panel to the U.S. Food and Drug Administration (FDA).

Aztreonam lysine for inhalation (AZLI) is being developed by Gilead Sciences, Inc with support from Cystic Fibrosis Foundation Therapeutics (CFFT). The drug would offer a much-needed antibiotic alternative for cystic fibrosis patients who battle recurrent lung infections and often develop resistance to existing antibiotics.

In the fall of 2007, results of the final Phase 3 trials were presented to the FDA in the form of a New Drug Application. At that time, unfortunately, a division of the FDA decided not to issue an approval letter for a number of reasons, which we believed were not sufficient to withhold approval. Working with Gilead we communicated with the FDA urging reconsideration.

Finally, in the spring of this year, the FDA reluctantly agreed to convene an advisory committee to review and provide non-binding recommendations to the staff. As you will see in the two links below, the committee voted 15−2 in favor of approving the New Drug Application! This is a major milestone vote for our patients in many ways.

The FDA staff has 60 days to make their ultimate decision, but with a 15−2 vote, it will be difficult for them to go against the panel's decision. More importantly, a strong message was sent by the committee to the FDA staff that in the case of CF, where few options are available, the bar for approval needs to be modified when the safety of the drug is not an issue. Clearly this was critical for numerous sponsors of new drugs to hear (many of whom were in attendance).

In a meeting of this kind, the sponsor (Gilead) presents its data, the FDA states its concerns, and then a public hearing is held. We organized this hearing and we had three compelling presentations by Drs. Bruce Marshall (CF Foundation) and Patrick Flume (Medical University of South Carolina), as well as by Beth Sufian, an adult with CF who manages our CF Legal Hotline. Their messages were powerful, and stressed the crucial need for new antibiotics against this insidious disease. Beth brought the audience to tears as she described the impact of this drug on her life and her future. She challenged the committee on why this drug was not yet approved in United States, while it was already approved in Canada and Europe. Dr. Frank Accurso likewise reinforced these points when he spoke on behalf of Gilead. They all did a superb job in telling our story.

What is exciting is, if − or better yet, when − this antibiotic is approved, it will be the first drug whose initial funding came from the CF Foundation's Therapeutics Development Program that receives FDA approval. Even more remarkable is that our drug development pipeline has dozens of promising potential drugs, which could dramatically improve and extend the lives of those with CF.

While we still need approval, yesterday's vote was a major milestone. It is because of you that we can make this kind of progress. Thank you for all you are doing to help advance our mission.


Best wishes for the holiday - this decision should make a happier holiday for all those affected by CF.

Sincerely,

The CF Foundation

No comments:

The Miracle of Transplantation

Pause the music player before watching.